Search Results - "Broughton, Howard"
-
1
A Residue-Resolved Bayesian Approach to Quantitative Interpretation of Hydrogen–Deuterium Exchange from Mass Spectrometry: Application to Characterizing Protein–Ligand Interactions
Published in The journal of physical chemistry. B (20-04-2017)“…Characterization of interactions between proteins and other molecules is crucial for understanding the mechanisms of action of biological systems and, thus,…”
Get full text
Journal Article -
2
Benchmarking causal reasoning algorithms for gene expression-based compound mechanism of action analysis
Published in BMC bioinformatics (18-04-2023)“…Elucidating compound mechanism of action (MoA) is beneficial to drug discovery, but in practice often represents a significant challenge. Causal Reasoning…”
Get full text
Journal Article -
3
MAVEN: compound mechanism of action analysis and visualisation using transcriptomics and compound structure data in R/Shiny
Published in BMC bioinformatics (15-09-2023)“…Abstract Background Understanding the Mechanism of Action (MoA) of a compound is an often challenging but equally crucial aspect of drug discovery that can…”
Get full text
Journal Article -
4
The Angiopoietin-Like Protein 3 and 8 Complex Interacts with Lipoprotein Lipase and Induces LPL Cleavage
Published in ACS chemical biology (19-03-2021)“…Lipoprotein lipase (LPL) is the key enzyme that hydrolyzes triglycerides from triglyceride-rich lipoproteins. Angiopoietin-like proteins (ANGPTL) 3, 4, and 8…”
Get full text
Journal Article -
5
The Chemical Basis of Serine Palmitoyltransferase Inhibition by Myriocin
Published in Journal of the American Chemical Society (25-09-2013)“…Sphingolipids (SLs) are essential components of cellular membranes formed from the condensation of l-serine and a long-chain acyl thioester. This first step is…”
Get full text
Journal Article -
6
Integration of phage and yeast display platforms: A reliable and cost effective approach for binning of peptides as displayed on-phage
Published in PloS one (01-06-2020)“…Hundreds of target specific peptides are routinely discovered by peptide display platforms. However, due to the high cost of peptide synthesis only a limited…”
Get full text
Journal Article -
7
Defining Target Engagement Required for Efficacy In Vivo at the Retinoic Acid Receptor-Related Orphan Receptor C2 (RORγt)
Published in Journal of medicinal chemistry (13-05-2021)“…The Th17 pathway has been implicated in autoimmune diseases. The retinoic acid receptor-related orphan receptor C2 (RORγt) is a master regulator of Th17 cells…”
Get full text
Journal Article -
8
Utilization of peptide phage display to investigate hotspots on IL-17A and what it means for drug discovery
Published in PloS one (12-01-2018)“…To date, IL-17A antibodies remain the only therapeutic approach to correct the abnormal activation of the IL-17A/IL-17R signaling complex. Why is it that…”
Get full text
Journal Article -
9
Mechanism of action deconvolution of the small-molecule pathological tau aggregation inhibitor Anle138b
Published in Alzheimer's research & therapy (14-03-2023)“…A key histopathological hallmark of Alzheimer's disease (AD) is the presence of neurofibrillary tangles of aggregated microtubule-associated protein tau in…”
Get full text
Journal Article -
10
Crystal structure of active CDK4-cyclin D and mechanistic basis for abemaciclib efficacy
Published in NPJ breast cancer (29-11-2022)“…Despite the biological and therapeutic relevance of CDK4/6 for the treatment of HR+, HER2- advanced breast cancer, the detailed mode of action of CDK4/6…”
Get full text
Journal Article -
11
Identification of a Novel, Selective GABAA α5 Receptor Inverse Agonist Which Enhances Cognition
Published in Journal of medicinal chemistry (22-05-2003)“…In pursuit of a GABAA α5-subtype-selective inverse agonist to enhance cognition, a series of 6,7-dihydro-2-benzothiophen-4(5H)-ones has been identified as a…”
Get full text
Journal Article -
12
Author Correction: Crystal structure of active CDK4-cyclin D and mechanistic basis for abemaciclib efficacy
Published in NPJ breast cancer (28-12-2022)Get full text
Journal Article -
13
Selection of heterocycles for drug design
Published in Journal of molecular graphics & modelling (01-09-2004)“…A method has been devised to obtain heterocyclic ring systems suitable for use in drug design and library design, with an emphasis on the selection of systems…”
Get full text
Journal Article -
14
N-Arylsulfonylindole Derivatives as Serotonin 5-HT6 Receptor Ligands
Published in Journal of medicinal chemistry (08-11-2001)“…A series of N 1-arylsulfonyltryptamines were found to be potent ligands of the human serotonin 5-HT6 receptor with the 5-methoxy-1-benzenesulfonyl analogue…”
Get full text
Journal Article -
15
-
16
Fluorination of 3-(3-(Piperidin-1-yl)propyl)indoles and 3-(3-(Piperazin-1-yl)propyl)indoles Gives Selective Human 5-HT1D Receptor Ligands with Improved Pharmacokinetic Profiles
Published in Journal of medicinal chemistry (17-06-1999)“…It has previously been reported that a 3-(3-(piperazin-1-yl)propyl)indole series of 5-HT1D receptor ligands have pharmacokinetic advantages over the…”
Get full text
Journal Article -
17
-
18
Stereocontrolled Synthesis of Cyclopropanol Amino Acids from Allylic Sulfones: Conformationally Restricted Building Blocks
Published in Organic letters (02-10-2003)“…A new amino acid methyl ester with a cyclopropanol has been synthesized starting from the allyl sulfone 10. The starting material, 10, could be obtained in…”
Get full text
Journal Article -
19
6,7-Dihydro-2-benzothiophen-4(5H)-ones: A Novel Class of GABA-A α5 Receptor Inverse Agonists
Published in Journal of medicinal chemistry (14-03-2002)“…Nonselective inverse agonists at the benzodiazepine binding site on the GABA-A chloride ion channel enhance cognitive performance in animals but cannot be used…”
Get full text
Journal Article -
20
A method for including protein flexibility in protein-ligand docking: improving tools for database mining and virtual screening
Published in Journal of molecular graphics & modelling (01-06-2000)“…Second-generation methods for docking ligands into their biological receptors, such as FLOG, provide for flexibility of the ligand but not of the receptor…”
Get full text
Journal Article